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Abstract
Background: Autosomal Recessive Primary Microcephaly (MCPH) is a disorder of neurogenic
mitosis. MCPH leads to reduced cerebral cortical volume and hence, reduced head circumference
associated with mental retardation of variable degree. Genetic heterogeneity is well documented
in patients with MCPH with six loci known, while pathogenic sequence variants in four respective
genes have been identified so far. Mutations in CDK5RAP2 gene at MCPH3 locus have been least
involved in causing MCPH phenotype.
Methods: All coding exons and exon/intron splice junctions of CDK5RAP2 gene were sequenced
in affected and normal individuals of Pakistani MCPH family of Kashmiri origin, which showed
linkage to MCPH3 locus on chromosome 9q33.2.
Results: A previously described nonsense mutation [243 T>A (S81X)] in exon 4 of CDK5RAP2
gene has been identified in the Pakistani family, presented here, with MCPH Phenotype. Genomic
and cDNA sequence comparison revealed that the exact nomenclature for this mutation is 246
T>A (Y82X).
Conclusion: Recurrent observation of Y82X mutation in CDK5RAP2 gene in this Pakistani family
may be a sign of confinement of a rare ancestral haplotype carrying this pathogenic variant within
Northern Pakistani population, as this has not been reported in any other population.
Background
Autosomal recessive primary microcephaly (MCPH), a
rare neurodevelopmental disorder, is characterized by
reduced head circumference of at least 4 standard devia-
tions below the age- and sex- related population specific
means; associated with non progressive mental retarda-
tion of variable degree but no other neurological deficit.
In individuals with MCPH phenotype, the brain weight is
markedly reduced and the cerebral cortex is dispropor-
tionately small with no major abnormalities in cortical
architecture [1,2]. MCPH is genetically heterogeneous
with six loci (MCPH1–MCPH6) mapped to date [3-8]
while four of the corresponding genes [Microcephalin
(MIM-607117) at MCPH1, CDK5RAP2 (MIM-608201) at
MCPH3, ASPM (MIM-605481) at MCPH5 and CENPJ
(MIM-609279) at MCPH6] have been identified [9-11].
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microcephaly world wide and at least 30 pathogenic
sequence variants in the corresponding gene ASPM
(abnormal spindle like microcephaly associated) are
known to date without any significant correlation
between position of mutation and severity of microceph-
aly [12-16]. ASPM has preferential expression in neuroep-
ithelium of the lateral ventricles during neurogenic cycle
and its various isoforms with different number of IQ
motifs have been detected in numerous tissues [17]. Four
mutations have been reported in Microcephalin gene at
MCPH1 locus, causing MCPH and an allelic form, PCC
(Premature chromosome condensation) syndrome (PCC;
606858), characterized by microcephaly, short stature,
and misregulated chromosome condensation [9,18-20].
Microcephalin functions as a proximal factor in the DNA
damage checkpoints that control multiple damage sen-
sors and early mediators and also implicated in cell cycle
checkpoints, controlling and regulating other important
molecules and thus affecting the timing of mitosis; its
depletion abolishes the DNA damage response and results
in centrosomal abnormalities and chromosomal aberra-
tions [21-23]. Three mutations in the CENPJ (centromere
associated protein J) gene at MCPH6 locus are known in
Brazilian and Pakistani families with autosomal recessive
primary microcephaly [11,24]. CENPJ encodes a centro-
somal protein which is associated with γ-tubulin ring
complex and in-vitro evidence suggested its role in inhibi-
tion of microtubule nucleation [25]. Therefore, a role for
CENPJ in centrosome duplication at the beginning of
mitosis has been proposed [26].
Mutations in Cyclin-dependent protein kinase 5, regula-
tory subunit associated protein 2, (CDK5RAP2) gene at
MCPH3 locus are least involved in causing MCPH pheno-
type. To date only two homozygous mutations (243T>A,
S81X) and (IVS26-15A>G) have been reported in this
gene in primary microcephaly patients [11]. The gene
CDK5RAP2 has a genomic size of 191290 bps and con-
tains 34 exons, with a transcript length of 6230 bps and
1893 translated residues [11,27]. The CDK5RAP2 gene
has predicted to contain one N-terminal spindle associ-
ated domain and two potential chromosome segregation
ATPase (SMC, structural maintenance of chromosomes)
domains, which are known to play a role in the cohesion
and condensation of chromosomes during mitosis [28].
The gene product concentrates at spindles poles during
prometaphase and metaphase [11,29]. Its localization to
the spindle poles of mitotic cells suggests involvement of
a centrosomal mechanism during mammalian brain
development [11]. CDK5RAP2 has a potential role in the
inhibition of centrosomal CDK5 during neurogenesis.
CDK5 is a promiscuous protein kinase only functioning
in the brain with neuron-specific roles in processes
including neurogenesis, neural migration and neurode-
generation [29].
In the present study, we report the identification of a pre-
viously described nonsense mutation 243 T>A (S81X) in
exon 4 of CDK5RAP2 gene in a Pakistani family of Kash-
miri origin.
Methods
Ascertainment of study subjects
The study was approved by the Institutional Review Board
(IRB) of Quaid-i-Azam University, Islamabad, Pakistan.
Informed consent was obtained from all family members
who agreed to participate in the study. A Pakistani consan-
guineous family of Kashmiri origin with four affected
individuals showing primary microcephaly was studied.
Medical and family history and information on pedigree
was obtained from multiple family members. Family ped-
igree provided convincing evidence of autosomal reces-
sive mode of inheritance (Figure 1) and consanguineous
loops accounted for all the affected persons being
homozygous for the mutant allele. To exclude the possi-
bility of chromosomal aberrations as the cause of micro-
cephaly, G-banding chromosomal analysis was carried
out in one affected individual.
Extraction of genomic DNA and genotyping
Genomic DNA was extracted from whole blood followed
by a standard protocol [30]. To establish linkage of the
family to known MCPH loci a minimum of five microsat-
ellite markers from each of the candidate regions were
genotyped in all the available individuals. Genetic map
distances of the markers used were obtained from Rutgers
Combined Linkage-Physical map [31]. Physical positions
of the markers were taken from NCBI Build 36.1 of the
International Human Genome Sequence Consortium
2007 [32] PEDCHECK [33] was used to identify Mende-
lian inconsistencies. Two point LOD score was calculated
using MLINK program of the FASTLINK computer pack-
age [34]. Multipoint LOD score was calculated by ALLE-
GRO [35]. An autosomal recessive mode of inheritance
with complete penetrance and a disease allele frequency
of 0.001 were used for the analysis.
PCR for each primer was performed in 25 μl reaction vol-
ume containing 40 ng of genomic DNA, 240 nM of prim-
ers, 200 uM of each dNTP, I U of Taq DNA polymerase
(Fermentas, UK), and 2.5 μl reaction buffer (KCl 50 mM,
Tris-HCl pH 8.3, MgCl2 15 mM). Details of microsatellite
markers used for genotyping and PCR amplification con-
ditions have been described elsewhere [16]. PCR products
were resolved on 8% non denaturing polyacrylamide gel
and genotypes were assigned by visual inspection.Page 2 of 7
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All coding exons and exon/intron splice junctions of
CDK5RAP2 gene (Gene Bank ID: NM_18249.4), were
PCR amplified from genomic DNA of two affected and
one normal individual of the family using primer
sequences designed from intronic sequences of the gene.
These sequences, designed by using Primer3 software
[36], are different from those described previously [11].
Pedigree drawing of family AFigu  1
Pedigree drawing of family A. Filled symbols represents individuals with MCPH phenotype, while clear symbols are for unaf-
fected individuals. Haplotypes are shown beneath each genotyped individual. Microsatellite analysis is consistent with linkage of 
the family to MCPH3.
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gene and their respective amplification conditions are
available on request.
After purification of PCR amplified product with Rapid
PCR amplification system (Marligen Bio-sciences, Ijam-
sville, MD, USA) sequencing was performed with the Big-
Dye Terminator version 3.1 Cycle Sequencing Kit,
together with an ABI Prism 310 Genetic Analyzer
(Applera, Foster City, CA, USA). Sequence variants were
identified via Bioedit, sequence alignment editor version
6.0.7. When a potentially functional sequence variant was
found, respective exon was sequenced in all other family
members for whom DNA was available.
Results
Clinical history indicated that microcephaly was present
by birth in all affected individuals. Head circumferences
of affected individuals were 4–7 standard deviations
below the age- and sex-related means. Affected individu-
als examined were 18 to 30 years old and mental retarda-
tion ranged from mild to moderate in severity. The facial
features of the affected individuals are normal except an
indistinct slopping forehead (Figure 2). With the excep-
tion of intellectual impairment, no other neurological
problems were observed in the affected individuals. The
intelligence quotient (IQ) scores for affected individuals,
measured at Children Hospital Lahore Pakistan, ranged
from 51 to 65. No environment causes could be found to
explain the findings of MCPH in this family.
Linkage of the family to MCPH3 locus was based on the
observation that all affected individuals were
homozygous with markers in the candidate region of
MCPH3 (Figure 1). According to International Human
Genome Sequence Consortium 2007 [32], a single 25 Mb
region of shared homozygosity- and allele-sharing among
the four affected individuals in this family was identified
at MCPH3 locus on chromosome 9q31.2–q34.1 between
markers D9S1801 and D9S1847. The maximum two
point LOD score of 1.58 (θ = 0) was obtained with several
markers including D9S302, D9S737, D9S762, D9S934,
D9S1682 and D9S242 [Table 1]. The maximum
Table 1: Two-point LOD score results between the MCPH3 locus and chromosome 9 markers





0.00 0.01 0.05 0.1 0.2 0.3
D9S1801 112.31 109425991 - inf -2.73 -1.39 -0.85 -0.37 -0.14
D9S930 117.84 114276019 1.28 1.25 1.14 1.00 0.71 0.43
D9S302 122.69 N.A 1.58 1.54 1.39 1.19 0.82 0.47
D9S737 124.75 118592918 1.58 1.54 1.39 1.19 0.82 0.47
D9S762 126.40 120135547 1.58 1.54 1.39 1.19 0.82 0.47
D9S934 129.82 120135477 1.58 1.54 1.39 1.19 0.82 0.47
D9S1682 130.73 124033005 1.58 1.54 1.39 1.19 0.82 0.47
D9S242 133.72 125908748 1.58 1.54 1.39 1.19 0.82 0.47
D9S1881 141.5 126019246 0.96 0.95 0.89 0.79 0.57 0.33
D9S1847 147.72 134426754 - inf -2.16 -0.89 -0.45 -0.13 -0.04
*-Cumulative sex-averaged Kosambi genetic map distances (cM) from the Rutgers combined linkage-physical map of the human genome [31].
**-Sequences-based physical map distances in bases according to NCBI Build 36.1 of the human reference sequence [32].
An affected individual (IV-5) of the Pakistani family AFigur  2
An affected individual (IV-5) of the Pakistani family A. Image 
has been shown with permission from the respective individ-
ual and his parent/guardian.Page 4 of 7
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markers in the candidate region. Sequence analysis of
exon 4 of the gene revealed a T to A transition at nucleo-
tide position 246 in all the affected individuals, resulting
in immediate premature stop at amino acid position 82
(Y82X). This mutation was present in heterozygous state
in the obligate carriers of the variant (Figure 3, 4). To
ensure that the mutation did not represent neutral poly-
morphisms in the population, a panel of 100 unrelated
unaffected individuals (200 chromosomes) was screened
for the mutations and it was not identified outside the
family.
Discussion
The study presented here described the identification of a
recurrent non-sense mutation (Y82X) in CDK5RAP2 gene
in a consanguineous Pakistani family of Kashmiri origin
linked to MCPH3 locus on chromosome 9q31.2–q34.1.
Elsewhere, Bond et al. [11] have reported two
homozygous mutations (243T>A and IVS26-15A>G) in
CDK5RAP2 gene in two families from Pakistan linked to
MCPH3 locus. According to the reference sequence
(NM_18249.4) the non-sense mutation [(246T>A) Y82X]
in CDK5RAP2 gene, reported here, is the same as that des-
ignated as S82X; [11]. Genomic and cDNA sequence
(Gene Bank ID: NM_18249.4) comparison revealed that
the actual position of nucleotide conversion is 246T>A,
which results in immediate premature stop at amino acid
position 82. Also the substituted amino acid was found to
be Tyrosine (Y) and not Serine (S) as reported previously
[11]. These findings are supported by ENSEMBL genome
browser [37] (Gene ID: ENSG00000136861, Transcript
A schematic representation of the nucleotide sequence (238–252) of xon 4 of CDK5RAP2 genFigur  4
A schematic representation of the nucleotide sequence 
(238–252) of exon 4 of CDK5RAP2 gene. An arrow indicates 
the nucleotide number 246 which is substituted by A in the 
patient DNA resulting in the mutation Y82X. The numbers 
above the nucleotide sequence represent the nucleotide 
numbers in the gene. The numbers below the single letter 
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Automated DNA sequence analysis of CDK5RAP2 gene muta-tion in th  familyFigure 3
Automated DNA sequence analysis of CDK5RAP2 gene muta-
tion in the family. Upper panel represents the sequence in an 
affected individual, middle panel in heterozygous carrier and 
lower panel in normal individual of the family.
( )Page 5 of 7
(page number not for citation purposes)
BMC Medical Genetics 2007, 8:58 http://www.biomedcentral.com/1471-2350/8/58ID: E T00000349780, Peptide ID: ENSP00000343818).
Alignment of the transcript sequence
(NM_18249.4CDK5RAP2 transcript variant 1) with the
genomic sequence (Genomic ref NC_000009.10
c122382258-122190968 Homo sapiens chromosome 9,
reference assembly, complete sequence) of CDK5RAP2
gene resulted in 38 hits referring to the presence of 38
translated exons in CDK5RAP2 transcript variant 1.
ENSEMBL entry corresponds to other database identifiers
as well i-e CCDS (ID: 6823.1), Entrez Gene (ID: 55755),
UniProtKB/Swiss-Prot [38] (ID: Q96SN8).
Although many ethnic groups speaking different lan-
guages such as Kashmiri, Hindko, Shina and Pashto live in
Northern Pakistan but according to George Grieson's clas-
sification all these ethnic groups are descends of a com-
mon ancestor of proto Indo-Aryan origin [39]. Recurrence
of Y82X mutation in CDK5RAP2 gene in our family of
Kashmiri origin may indicate confinement of this rare
haplotype within Northern Pakistani population. This
family is only the third MCPH family, which showed link-
age to MCPH3 locus. Family with primary microcephaly
belongs to Rajput Biradiri of District Mirpur, in Azad
Jammu and Kashmir, a region bordering India and Paki-
stan. Due to social and religious customs, consanguineous
marriages are a common practice in this population.
MCPH is thought to affect neuronal precursor cell divi-
sion and hence, primarily a consequence of neurogenic
mitosis [1,2]. Immunohistochemistry and confocal
microscopy of N-terminal antibodies in HeLa cells
showed presence of CDK5RAP2 at centrosome through-
out mitosis and it has been hypothesized that an uniden-
tified centrosomal mechanism controls the number of
neurons generated by neural precursor cells [11]. There-
fore, it may be concluded that mutations in CDK5RAP2
affect neurogenic mitosis by reducing the number of
microtubules needed to build mitotic spindle and astral
microtubule network [29].
Conclusion
Identification of a recurrent mutation (Y82X) in
CDK5RAP2 gene in the family studied strengthens the role
of this particular mutation in the pathogenesis of the
MCPH.
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